1US Departmentof Healthand Human Services Monograph，1996年，30页
2Hatanaka K，Pathol Int，1995年，45卷，631页
3Liuzzo G，New Engl J Med，1994年，331卷，417页
4Libby P, Ridker PM. Novel inflammatory markers of coronary risk ." theory versus practice[ J]. Circulation, 1999,100( 11 ) : 1148-1150.
5Torzewski J, Torzewski M, Bowyer DE, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atheroscleretic lesions of human coronary arteries[ J]. Arterioscler Thremb Vasc Biol, 1998,18(9) : 1386-1392.
7Haverkate F, Thompson SG ,Pyke SD, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group[J]. Lancet, 1997,349(9050) :462-466.
8Sorelle R.Weight loss decreases C-reactive protein levels[J].Circulation.2002,105(5):E9071-9072.
9Liu S,Manson JE,Buring JE,et al.Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women[J].Am J Clin Nutr,2002,75(3):492-498.
10Sacks FM,Ridker PM.Lipid lowering and beyond:results from the CARE study on Lipoproteins and inflammation.Cholesterol and Recurrent Events[J].Herz,1999,24(1):51-56.
2Tenenbaum A, Fisman EZ, Motro M. Toward a redefinition of is- chemiccardiomyopathy :is it all indivisible entity [J]. J Am Coil Cardio 1,2002,40 ( 1 ) : 205 -206.
3Mendis S, Ranatunga P, Jayatilake M, et al. Hyperhomocystein- aemia inSri Lan-kan patients with coronary artery disease [J]. Ceylon Med J, 2002,47 (3) : 89-92.
4Moreno R, ovidio AD, Zamorano J, et al. Distinguishing between ischemic and non--ischemic dilated cardiomyopathy based on non-invasive ultrasonic evaluation of peripheral arteries[J]. Eur J Intern Med, 2005,16 ( 1 ) : 41-46.
